Moyamoya disease

Moyamoya disease is a disorder of the blood vessels in the brain, mainly the internal carotid arteries and the arteries that branch from them. These vessels narrow over time, which reduces blood flow to the brain. New networks of small, fragile vessels form, and on an angiogram they look like puffs of smoke, which is how the disease got its Japanese name. The reduced blood supply can cause temporary stroke-like episodes (transient ischemic attacks), strokes and seizures, and the fragile vessels can develop bulges (aneurysms) or break open and bleed into the brain. It mostly affects children but can also occur in adults. A US government genetics page, last updated in 2017, says it commonly begins around age 5 or in a person's thirties or forties, and that symptoms often worsen over time if the condition is not treated.

Also called Moyamoya · Moya-moya disease

  • Condition
  • In this atlas

Overview

Technical summary

MeSH descriptor D009072 (Moyamoya Disease). Its scope note describes a noninflammatory, progressive occlusion of the intracranial carotid arteries with the formation of netlike collateral arteries arising from the circle of Willis, and says the disease primarily affects children but can also occur in adults. A US government genetics page (last updated October 1, 2017) describes narrowing of the internal carotid arteries and their branches, compensating small fragile vessels with a puff-of-smoke look on angiography, onset around age 5 or in the thirties or forties, symptoms that include transient ischemic attacks, strokes and seizures, and bulges (aneurysms) or bleeding from the fragile vessels. It says the disease was first identified in Japan, where it is most prevalent, affecting about 5 in 100,000 individuals, that it occurs twice as often in females as in males for unknown reasons, and that changes in one gene, RNF213, have been associated with it. It uses the term moyamoya syndrome for people who have these blood vessel changes together with another disorder. Those figures are from the 2017 page and have not been rechecked against newer sources. This page gives no treatment information. The text rests on the MeSH scope note and that genetics page.

Recognition

A US government genetics page (last updated in 2017) says the lack of blood supply to the brain leads to temporary stroke-like episodes (transient ischemic attacks), strokes and seizures, and that the symptoms often worsen over time if the condition is not treated.

Burden

No burden claims are published.

Claims and evidence

No claims are published for this condition yet.

Registry records

Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry trials 4

Record details

Record id
cardio:moyamoya-disease
Content hash
f740288906efdc52b7844babdc4c30a8826959f7918da9b72f9c993184058244